Muszalska-Kolos I - Search Results

1

Tricyclic Derivative of Acyclovir and Its Esters in Relation to the Esters of Acyclovir Enzymatic Stability: Enzymatic Stability Study.

Muszalska-Kolos I, Lesniewska-Kowiel MA, Plewa S, Klupczyńska A. Muszalska-Kolos I, et al. Molecules. 2020 May 5;25(9):2156. doi: 10.3390/molecules25092156. Molecules. 2020. PMID: 32380673 Free PMC article.

2

Choline Salicylate Analysis: Chemical Stability and Degradation Product Identification.

Wróblewska KB, Plewa S, Dereziński P, Muszalska-Kolos I. Wróblewska KB, et al. Among authors: muszalska kolos i. Molecules. 2019 Dec 22;25(1):51. doi: 10.3390/molecules25010051. Molecules. 2019. PMID: 31877863 Free PMC article.

3

Novel Formulation of Eye Drops Containing Choline Salicylate and Hyaluronic Acid: Stability, Permeability, and Cytotoxicity Studies Using Alternative Ex Vivo and In Vitro Models.

Wróblewska KB, Milanowski B, Kucińska M, Plewa S, Długaszewska J, Muszalska-Kolos I. Wróblewska KB, et al. Among authors: muszalska kolos i. Pharmaceuticals (Basel). 2021 Aug 26;14(9):849. doi: 10.3390/ph14090849. Pharmaceuticals (Basel). 2021. PMID: 34577550 Free PMC article.

4

Design and evaluation of pharmaceutical availability, stability and quality of modified viscosity eye drops with choline salicylate.

Wróblewska KB, Plewa S, Długaszewska J, Froelich A, Muszalska-Kolos I. Wróblewska KB, et al. Among authors: muszalska kolos i. Eur J Pharm Sci. 2021 Apr 1;159:105725. doi: 10.1016/j.ejps.2021.105725. Epub 2021 Jan 19. Eur J Pharm Sci. 2021. PMID: 33482319

5

Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.

Wróblewska KB, Jadach B, Muszalska-Kolos I. Wróblewska KB, et al. Among authors: muszalska kolos i. Int J Pharm. 2021 Sep 25;607:121012. doi: 10.1016/j.ijpharm.2021.121012. Epub 2021 Aug 13. Int J Pharm. 2021. PMID: 34400274 Free article. Review.

6

Critical Points in the Methodology of Preparing Copper (II) Histidinate Injections and their Quality Assessment Applying Color Measurement.

Dwiecki PM, Wróblewska KB, Krzywańska J, Parmonik A, Muszalska-Kolos I. Dwiecki PM, et al. Among authors: muszalska kolos i. J Pharm Sci. 2022 Sep;111(9):2471-2480. doi: 10.1016/j.xphs.2022.03.015. Epub 2022 Mar 24. J Pharm Sci. 2022. PMID: 35341720

7

Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review.

Piwowarczyk L, Stawny M, Mlynarczyk DT, Muszalska-Kolos I, Goslinski T, Jelińska A. Piwowarczyk L, et al. Among authors: muszalska kolos i. Cancers (Basel). 2020 Jul 5;12(7):1801. doi: 10.3390/cancers12071801. Cancers (Basel). 2020. PMID: 32635637 Free PMC article. Review.

8

Tuberculosis - Present Medication and Therapeutic Prospects.

Jelińska A, Zając M, Dadej A, Tomczak S, Geszke-Moritz M, Muszalska-Kolos I. Jelińska A, et al. Curr Med Chem. 2020;27(4):630-656. doi: 10.2174/0929867325666181120100025. Curr Med Chem. 2020. PMID: 30457045

9

Role of curcumin in selected head and neck lesions. Limitations on the use of the Hep-2 cell line: A critical review.

Piwowarczyk L, Stawny M, Piwowarczyk K, Mlynarczyk DT, Muszalska-Kolos I, Wierzbicka M, Goslinski T, Jelinska A. Piwowarczyk L, et al. Among authors: muszalska kolos i. Biomed Pharmacother. 2022 Oct;154:113560. doi: 10.1016/j.biopha.2022.113560. Epub 2022 Aug 26. Biomed Pharmacother. 2022. PMID: 36030583 Free article. Review.

10

Searching for Conjugates as New Structures for Antifungal Therapies.

Muszalska-Kolos I, Dwiecki PM. Muszalska-Kolos I, et al. J Med Chem. 2024 Mar 28;67(6):4298-4321. doi: 10.1021/acs.jmedchem.3c01750. Epub 2024 Mar 12. J Med Chem. 2024. PMID: 38470824 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page